Spirig Pharma Ltd.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis (NCT01792713) | Spirig Pharma Ltd. | 2013-02-01 |
| Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma (NCT01808950) | Spirig Pharma Ltd. | 2013-02-01 |
| Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis. (NCT01806961) | Spirig Pharma Ltd. | 2013-01-01 |
| Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions (NCT01583816) | Spirig Pharma Ltd. | 2012-05-01 |
| Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients (NCT01532453) | Spirig Pharma Ltd. | 2010-11-01 |
| Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) (NCT01146444) | Spirig Pharma Ltd. | 2009-11-01 |
Track Spirig Pharma Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.